A Phase IB/II, Open-Label, Multicenter, Randomized, Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Locally Advanced Unresectable Or Metastatic Gastric Or Gastroesophageal Junction Cancer Or Esophageal Cancer (Morpheusgastric And Esophageal Cancer)

  • Strickland, Andrew (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: Peter Mac ref 20/97
NMA SSA Reference Number: SSA/64485/MonH-2020-230516(v1)
Monash Health Reference: RES-20-0000-645X
Effective start/end date8/10/207/10/25


  • clinical trial
  • phase 1 study
  • treatment safety
  • treatment efficacy
  • Esophageal Cancer
  • gastric cancer